Previous clinical data have implicated that upregulated expression of CXCL12 and CXCR4 in plasma or atria of AF patients is associated with excessive atrial remodeling, longer hospital stay, and even a higher mortality risk [13–15]. The gene discussed is CXCL12; the disease is atrial fibrillation.